
About Supreem Pharmaceuticals
Supreem Pharmaceuticals is an Agriculture company based in Bengaluru (India) founded in 1985. It manufactures stabilized vitamins, minerals, and herbal extracts for food, pharma, and beauty sectors. It operates on a B2B and D2C model in Agriculture and Healthcare sectors. The company has 207 employees. Its Indian entity Supreem Pharmaceuticals Mysore Private Limited reported revenue of βΉ82.17 Cr. Supreem Pharmaceuticals offers products and services including Stabilized Vitamins, Herbal Extracts, Tasteless Minerals, and Value Added APIs. Its focus areas include Food and Agriculture Tech, Food Ingredients, Dietary Supplements and Vitamins. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Supreem Pharmaceuticals produces stabilized vitamins, minerals, and herbal extracts to enhance product stability and shelf life. They use expert RD to address sensitivity issues in food and pharmaceutical applications. Based in Mysuru, India, they serve over 400 customers across 30 export countries with certified, high-quality solutions for dietary supplements and cosmetic ingredients.
- Headquarters Bengaluru, India
- Employees 207
- SectorsAgricultureHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website supreempharma.in
- Social LinkedIn X Facebook
- Legal Name Supreem Pharmaceuticals Mysore Private Limited
- Date of Incorporation 16 Aug, 1996
- Jurisdiction Nanjangudu, Karnataka, India
- Annual Revenue₹82.17 Cr
FY 2025 · +21% YoY
- Net Profit₹2.28 Cr
FY 2025 · 3% margin
- EBITDA₹7.24 Cr
FY 2025 · 9% margin
- Employee Count207
Associated legal entities of Supreem Pharmaceuticals
Supreem Pharmaceuticals operates through Supreem Pharmaceuticals Mysore Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Supreem Pharmaceuticals Mysore Private Limited CIN U24231KA1996PTC020988 | Active | 16 Aug 1996 | Nanjangudu, Karnataka | ₹82.2 Cr | 207 | 4 | View details |
Products & Services of Supreem Pharmaceuticals
Supreem Pharmaceuticals offers a comprehensive portfolio of products and services, including Stabilized Vitamins, Herbal Extracts, Tasteless Minerals, and Value Added APIs.
Enhanced vitamins for stability in food and pharma applications.
Extracts from pesticide-free materials for safe human use.
Minerals formulated for compatibility in beverages and supplements.
Active ingredients with improved stability for therapeutic uses.
Board of directors of Supreem Pharmaceuticals Mysore Private Limited (Supreem Pharmaceuticals)
Supreem Pharmaceuticals Mysore Private Limited is the primary company behind Supreem Pharmaceuticals. The board of Supreem Pharmaceuticals Mysore Private Limited currently have 4 directors; the longest-serving is Sadanand Nagaraja Rao, appointed in 1996. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sadanand Nagaraja Rao DIN 00390316 | Managing Director | 16 Aug 1996 | 30 yrs 2 mo | Supreem Pharmaceuticals Mysore Private Limited |
| Geetha Sadananda Nagaraja Rao DIN 01970187 | Whole-time director | 22 Jan 2008 | 18 yrs 9 mo | Supreem Pharmaceuticals Mysore Private Limited |
| Aditya Sadanand Rao DIN 08766120 | Whole-time director | 10 Jul 2020 | 6 yrs 4 mo | Supreem Pharmaceuticals Mysore Private Limited |
| Amit Sadanand Rao DIN 08766238 | Whole-time director | 10 Jul 2020 | 6 yrs 4 mo | Supreem Pharmaceuticals Mysore Private Limited |
Financials of Supreem Pharmaceuticals
Figures of Supreem Pharmaceuticals Mysore Private Limited, the primary company behind Supreem Pharmaceuticals, for FY 2025. Revenue was ₹82.17 Cr (+21% year on year). Net profit was ₹2.28 Cr (3% margin). EBITDA was ₹7.24 Cr (9% margin). Revenue has grown at a compounded annual rate of +2% over three years and +11% over five years.
- ₹82.17 CrRevenue · FY 2025 · +21% YoY
- ₹2.28 CrNet profit · 3% margin
- ₹7.24 CrEBITDA · 9% margin
- ₹3.94 CrPaid-up capital
- 207Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Supreem Pharmaceuticals Mysore Private Limited are on its company page.
Detailed financial statements for Supreem Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Supreem Pharmaceuticals
Supreem Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Supreem Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Supreem Pharmaceuticals
Websites that share an audience with Supreem Pharmaceuticals (supreempharma.in).
Websites whose visitors overlap most with Supreem Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details | |
apps.facebook.com | apps.facebook.com | 100% | β |
Top companies in Animal Feed & Nutrition
3 companies that operate in the same segment as Supreem Pharmaceuticals (Animal Feed & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Procures and distributes milk and dairy products through unions and online orders. | 1984 | Bengaluru, Karnataka, India | USD 5.53 M | 355 | ||
A brand specializing in high-quality milk and food products. | 2007 | Lucknow, Uttar Pradesh, India | USD 207.22 M | 1,089 | ||
Provides healthy snack options including potato chips, multigrain chips, and noodles for consumers. | 2016 | Kolkata, West Bengal, India | USD 50.08 M | 4 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Supreem Pharmaceuticals
Complete news archive for Supreem Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supreem Pharmaceuticals
Supreem Pharmaceuticals was founded in 1985.
Supreem Pharmaceuticals is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Supreem Pharmaceuticals has 207 employees.
The primary company behind Supreem Pharmaceuticals, Supreem Pharmaceuticals Mysore Private Limited, reported revenue of βΉ82.17 Cr for FY 2025, up 21% year on year.
Supreem Pharmaceuticals produces stabilized vitamins, minerals, and herbal extracts to enhance product stability and shelf life. They use expert RD to address sensitivity issues in food and pharmaceutical applications. Based in Mysuru, India, they serve over 400 customers across 30 export countries with certified, high-quality solutions for dietary supplements and cosmetic ingredients.
Supreem Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Supreem Pharmaceuticals offers Stabilized Vitamins, Herbal Extracts, Tasteless Minerals, and Value Added APIs.
Supreem Pharmaceuticals operates through Supreem Pharmaceuticals Mysore Private Limited.
The legal entities of Supreem Pharmaceuticals currently have 4 directors, including Geetha Sadananda Nagaraja Rao, Aditya Sadanand Rao, Amit Sadanand Rao and others.
